ZTEK Zentek Ltd Cumulative Company Assets

Official company branding of Zentek Ltd (ZTEK)

Zentek Ltd is establishing a cutting-edge nanotechnology environment by integrating graphene structures into the industrial sector and virus diagnostics. The company is implementing automated nanomaterial production facilities and digitizing sensor calibration. The business relies on unique biosynthesis patents and strict sanitary standards to create antibacterial layers for masks. The price action of total assets, which stands at 17.65, is illustrated in the chart below.

Company Total Assets: Zentek Ltd (ZTEK) for 04/28/2023 - 09/12/2026

Financial and market metric breakdowns for Zentek Limited (ZTEK)

- market value and analyst target forecast:
Stock Price zentek.com|ZTEK - Price Target Chart
- market capitalization data:
Market Valuation Zentek Corp|ZTEK - Enterprise Value
- company book value details:
Net Asset Value per Share Zentek|ZTEK - Book Capitalization|Capitalization to Book Value Ratio zentek.com|ZTEK - Company Total Assets
- debt burden and liquidity indicators:
Total Debt to Capital Coefficient Zentek Ltd.|ZTEK - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Zentek Corp|ZTEK - Company Aggregate Debts|Debts to Book Capitalization Zentek Corp|ZTEK - Company Long-Term Debt|Company Short-Term Debt Zentek|Intermediate Coverage Ratio zentek.com
- company profitability and valuation multiples indicators:
ZTEK - Net Profit
Fundamental valuation:Zentek Ltd.
Mass-produced product of Zentek Ltd.

For Zentek Ltd., which is scaling nanomaterial production and expanding into the medtech sector, resource volume is critical for executing B2B contracts. The current value of 17.65 reflects the total capital and debt calculated reverse-engineered through ROA; by analyzing the asset trajectory via ROA, an investor determines the actual scale of the business and the resilience of the share price to market shocks.

Main competitors

intuitive.com (ISRG) - Company Total Assets|Aggregate Company Assets Danaher|Cumulative Company Assets BD (BDX)|Company Total Assets STE|WST - Company Assets|Company Total Assets BAX (Baxter International)|MASI: Total Business Assets|Stevanato Group - Company Total Assets|Company Total Asset Base Teleflex Inc. TFX|MMSI: Company Total Assets|Cumulative Company Assets Nobel Biocare|ICUI (ICU Medical, Inc.) - Company Total Assets|Company Total Assets dentsplysirona.com|Aggregate Company Assets LeMaitre Vascular (LMAT)|Aggregate Company Assets ATRC (AtriCure Inc)|STAAR Surgical Corp - Cumulative Company Assets|Aggregate Asset Value NAGE|ZimVie Inc. - Company Total Assets|Company Total Asset Base angiodynamics.com ANGO|Cerus (CERS) - Aggregate Company Assets|Total Business Assets TKNO|Aggregate Company Assets Monogram Technologies Inc|Sharps Tech (STSS) - Company Total Asset Base|Cumulative Company Assets INFU (InfuSystem Holdings)|Aggregate Business Assets UTMD|Aggregate Company Assets KORU Medical KRMD|Aggregate Asset Value NYXH|MBOT: Cumulative Company Assets|PDEX - Company Total Assets|Elutia Inc. (ELUT) - Aggregate Company Assets|Cumulative Company Assets milestonescientific.com|NXGL (NEXGEL) - Company Total Assets|Company Assets Retractable Tech RVP|Aggregate Company Assets Harvard Bioscience (HBIO)|Femasys Corporation - Total Business Assets|Meihua Medical Technologies Co., Ltd. - Cumulative Company Assets|Aggregate Business Assets POAI (Predictive Oncology Inc)|CJMB - Aggregate Company Assets|Company Total Asset Base Atrion Corp. ATRI|NURO (NeuroMetrix Corp) - Cumulative Company Assets